Sophie Metivier

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Journal: Journal of hepatology

Published: July 08, 2025

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis.

Journal: Journal of hepatology

Published: July 08, 2025

Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.

Safety and efficacy of REP 2139-Mg in patients with HDV-related advanced liver disease in an international compassionate access program.

Journal: Journal of hepatology

Published: April 11, 2025

Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis C.

Relink Programmes: Impact of Reengagement on Linkage to Care Across 82 006 People With Hepatitis C.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 27, 2025

Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.

Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis.

Journal: Journal of hepatology

Published: July 20, 2024

Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study.

Direct Antivirals Can Achieve a Cure in All Patients With Chronic Hepatitis C due to Genotype 5: A French Multicentre Study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 08, 2024

Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis.

Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis.

Journal: Journal of hepatology

Published: July 02, 2024

Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide.

Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide.

Journal: JHEP reports : innovation in hepatology

Published: January 30, 2024

Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort.

Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort.

Journal: JHEP reports : innovation in hepatology

Published: October 18, 2023

Corrigendum.

Corrigendum.

Journal: Alimentary pharmacology & therapeutics

Published: October 26, 2021

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis.

Journal: BMC infectious diseases

Published: July 16, 2021

Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.

Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study.

Journal: Clinics and research in hepatology and gastroenterology

Published: February 09, 2021

Showing 1-12 of 41

Last Updated: 09/26/2026